![Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer | Journal of Clinical Oncology Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2015/jco.2014.59.33.issue-3/jco.2014.55.1192/20161107/images/medium/zlj00315-4947-t02.jpeg)
Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer | Journal of Clinical Oncology
![Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0302283806013613-gr2.jpg)
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect
![PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy - ScienceDirect PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1558767319302514-gr1.jpg)
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy - ScienceDirect
![A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy | Radiation Oncology | Full Text A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1748-717X-8-170/MediaObjects/13014_2013_Article_893_Fig2_HTML.jpg)
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy | Radiation Oncology | Full Text
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://www.intechopen.com/media/chapter/41807/media/image15.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://www.intechopen.com/media/chapter/41807/media/image6.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://www.intechopen.com/media/chapter/41807/media/image2.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![PDF] Implications of prostate-specific antigen doubling time as indicator of failure after surgery or radiation therapy for prostate cancer. | Semantic Scholar PDF] Implications of prostate-specific antigen doubling time as indicator of failure after surgery or radiation therapy for prostate cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/71cfa2179a99d10f7ff92b04e89bbc6096deea17/3-Figure3-1.png)
PDF] Implications of prostate-specific antigen doubling time as indicator of failure after surgery or radiation therapy for prostate cancer. | Semantic Scholar
European Association of Urology - During follow-up, if mpMRI is negative (PI-RADS ≤ 2), and clinical suspicion of prostate cancer progression is low (low PSA velocity, long PSA doubling time), omit biopsy
![Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer](https://www.spandidos-publications.com/article_images/mco/6/2/mco-06-02-0249-g00.jpg)
Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer
![Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients](https://static.hindawi.com/articles/bmri/volume-2022/7943609/figures/7943609.fig.002c.jpg)
Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://www.intechopen.com/media/chapter/41807/media/image5.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies | Journal of Urology Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies | Journal of Urology](https://www.auajournals.org/cms/asset/9c876960-a4cf-4309-b4a7-ddadf842a855/abs-fig.jpg)
Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies | Journal of Urology
![Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen](https://www.intechopen.com/media/chapter/41807/media/image11.png)
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
![Kaplan-Meier Analysis of PSA Doubling Time. Freedom from biochemical... | Download Scientific Diagram Kaplan-Meier Analysis of PSA Doubling Time. Freedom from biochemical... | Download Scientific Diagram](https://www.researchgate.net/publication/247771095/figure/fig2/AS:216435726000130@1428613706360/Kaplan-Meier-Analysis-of-PSA-Doubling-Time-Freedom-from-biochemical-failure-A-freedom.png)
Kaplan-Meier Analysis of PSA Doubling Time. Freedom from biochemical... | Download Scientific Diagram
![Long-term outcome of detectable PSA levels after radical prostatectomy | Prostate Cancer and Prostatic Diseases Long-term outcome of detectable PSA levels after radical prostatectomy | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.pcan.4500788/MediaObjects/41391_2005_Article_BF4500788_Fig2_HTML.jpg)